Moxisolv LA 100 mg/ml Solution For Injection For Cattle

Moxisolv LA is indicated for the treatment and prevention of mixed infestations by the following gastro-intestinal nematodes, respiratory nematodes and certain arthropod parasites:

Adult and immature gastro-intestinal nematodes:
Haemonchus placei
Haemonchus contortus
Ostertagia ostertagi (including inhibited larvae)
Trichostrongylus axei
Trichostrongylus colubriformis
Nematodirus helvetianus (adults only)
Nematodirus spathiger
Cooperia surnabada
Cooperia oncophora
Cooperia pectinata
Cooperia punctata
Oesophagostomum radiatum

Bunostomum phlebotomum (adults only)
Chabertia ovina (adults only)
Trichuris spp. (adults only)

Adult and immature respiratory tract nematode:
Dictyocaulus viviparus

Warble grubs (migrating larvae):
Hypoderma bovis
Hypoderma lineatum

Lice:
Linognathus vituli
Haematopinus eurysternus
Solenopotes capillatus
Bovicola bovis (reduction of infestation)

Mange mites:
Sarcoptes scabiei
Psoroptes ovis
Chorioptes bovis (reduction of infestation)

Moxidectin has a persistent action and protects cattle for a certain duration against infection or re-infection with the following parasites for the period indicated:

Dictyocaulus viviparus - 120 days
Ostertagia ostertagi - 120 days
Haemonchus placei - 90 days
Oesophagostomum radiatum - 150 days
Trichostrongylus axei - 90 days
Linognathus vituli  - 133 days

Moxidectin LA is effective against Hypoderma larvae at the time of treatment but its persistent activity against Hypoderma has not been evaluated. If the
veterinary medicinal product is given before the end of the fly season complimentary treatment with a product effective against Hypoderma may be required.

Persistent efficacy periods have not been established for parasite species other than those included in the above list. Therefore, re-infection of animals on pasture contaminated by parasites other than these remains possible before the end of the 90-day minimum persistency period demonstrated for specific species.

Do not use in animals less than 100kg bodyweight or greater than 500kg.

Administration routes and dosage: 
Subcutaneous use. The dose is 1mg of Moxidectin per kg bodyweight (equivalent to 0.5ml of Moxidectin LA per 50kg bodyweight, given by a single subcutaneous injection in the ear - please see packaging or SPC for further information. Shake well before use.

Withdrawal periods: 
Meat and offal: 108 days.
Milk: Not authorised for use in animals producing milk for human consumption. Do not use in pregnant animals which are intended to produce milk for human consumption within 80 days of expected parturition.

The withdrawal period is based solely on a single injection at the ear site of injection.

DATASHEET: Moxisolv LA